Linked Data API

Show Search Form

Search Results

1343631
registered interest false more like this
date less than 2021-07-05more like thismore than 2021-07-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will provide an update on his plans to conduct research into the efficacy of a third covid-19 vaccine booster dose for immunocompromised and immunosuppressed groups. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith more like this
uin 27122 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-07-13more like thismore than 2021-07-13
answer text <p>The COV-BOOST study was commissioned through the National Institute for Health Research and will provide vital data on the impact of a third dose on patients’ immune responses. Initial findings are expected in September. To fully understand how COVID-19 vaccines respond as a booster dose they must first be studied in people with a fully functioning immune system.</p><p>UK Research and Innovation is providing £4 million towards the OCTAVE study examining COVID-19 vaccine responses in clinically at-risk groups, including immunocompromised patients.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-07-13T15:36:39.643Zmore like thismore than 2021-07-13T15:36:39.643Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
3960
label Biography information for Henry Smith remove filter